Wird geladen...

Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

BACKGROUND: Nintedanib is an inhibitor of receptor tyrosine kinases, including vascular endothelial growth factor receptor, but its effects on pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients with chronic hypoxia were unclear. METHODS: This study included a nintedanib pros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Pulm Med
Hauptverfasser: Tahara, Masahiro, Oda, Keishi, Yamasaki, Kei, Kawaguchi, Takako, Sennari, Konomi, Noguchi, Shingo, Sakamoto, Noriho, Kawanami, Toshinori, Mukae, Hiroshi, Yatera, Kazuhiro
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704493/
https://ncbi.nlm.nih.gov/pubmed/31438928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0918-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!